✦ LIBER ✦

Double-Blind Controlled Study of L-Dopa Therapy in Schizophrenia

✍ Scribed by Kazutoyo Inanaga; Yoichi Nakazawa; Katsumi Inoue; Hisayuki Tachibana; Masachika Oshima; Tatayu Kotorii; Masatoshi Tanaka; Nobuya Ogawa

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ondansetron. A double blind placebo cont

✍ McBain, S.L.; Dineen, M.; Weller, M.; Taylor, S.; Cooksey, P.; Williams, P.; Cor 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 106 KB

Cholecystokinin-octapeptide in chronic s

✍ Nair, N.P.V.; Bloom, D.M.; Debonnel, G.; Schwartz, G.; Mosticyan, S. 📂 Article 📅 1984 🏛 Elsevier Science 🌐 English ⚖ 234 KB

L-Dopa Modulates Functional Connectivity

✍ AMC Kelly; G de Zubicaray; A di Martino; D Copland; PT Reiss; DF Klein; FX Caste 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 117 KB

TREATMENT OF PARKINSON'S SYNDROME WITH L

✍ Clas Fehling 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 330 KB

Antiparkinsonian drug-induced sleepiness

✍ Joëlle Micallef; Marc Rey; Alexandre Eusebio; Christine Audebert; Frank Rouby; E 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 715 KB

Treatment of chronic schizophrenia with

✍ Henry Silver; Michael Blacker; Malcolm P.I. Weller; Bernard Lerer 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 396 KB